4.8 Article

Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia

Ifat Geron et al.

Summary: This study reveals that activating mutations in Interleukin-7 receptor alpha can initiate preleukemia in primary human hematopoietic progenitors and cooperate with CDKN2A silencing in the progression into acute lymphoblastic leukemia (BCP-ALL).

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples

Aleksandr Ianevski et al.

Summary: SynergyFinder is a free web application that allows interactive analysis and visualization of multi-drug combination response data. The latest upgrade, SynergyFinder 3.0, introduces new features such as interactive multisample analysis of combination synergy, a novel consensus synergy score, and improved outlier detection functionality. These improvements enable robust identification of consistent combinatorial synergies.

NUCLEIC ACIDS RESEARCH (2022)

Article Oncology

PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia

Jianping Li et al.

Summary: Mutations in the NSD2 histone methyltransferase (p.E1099K) were found to drive the relapse of pediatric acute lymphoblastic leukemia (ALL). These NSD2-mutant cells exhibited resistance to glucocorticoids, which was restored by correcting the mutation. The resistance was due to decreased expression of glucocorticoid receptor (GR) and the failure of glucocorticoids to activate GR expression. The use of PRC2 inhibitors reversed the glucocorticoid resistance by restoring GR levels and activation of proapoptotic genes, providing a potential therapeutic approach for relapsed ALL associated with NSD2 mutation.

CANCER DISCOVERY (2022)

Article Pharmacology & Pharmacy

Association Between NR3C1 Mutations and Glucocorticoid Resistance in Children With Acute Lymphoblastic Leukemia

Haiyan Liu et al.

Summary: This study investigated the association between NR3C1 gene mutations and treatment outcomes in pediatric acute lymphoblastic leukemia (ALL), finding that NR3C1 mutations are associated with glucocorticoid resistance. Loss-of-function (LoF) NR3C1 mutations influence GC resistance, indicating that NR3C1 alterations play a critical role in GC resistance and may contribute to treatment failure and relapse in ALL.

FRONTIERS IN PHARMACOLOGY (2021)

Review Oncology

Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Claudio Cerchione et al.

Summary: Acute leukemia, especially ALL, is the most common cancer in childhood with significantly improved survival rates over the years. The treatment for Ph+ALL in children has evolved from intensive chemotherapy and HSCT to a combination of TKIs and standard chemotherapy. The role of TKIs in pediatric Ph+ALL treatment has shown better outcomes compared to traditional treatments like HSCT.

FRONTIERS IN ONCOLOGY (2021)

Review Immunology

Glucocorticoids in T cell development, differentiation and function

Matthew D. Taves et al.

Summary: Glucocorticoids have dual effects on the immune system, promoting and suppressing T cell immunity. They shape T cell responses in various ways, such as selecting appropriate T cell receptor self-affinities and regulating T cell trafficking between anatomical compartments.

NATURE REVIEWS IMMUNOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Glucocorticoids Regulate Bone Marrow B Lymphopoiesis After Stroke

Gabriel Courties et al.

CIRCULATION RESEARCH (2019)

Article Oncology

CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic Leukemia

Jusus Duque-Afonso et al.

CANCER RESEARCH (2018)

Article Oncology

Single-cell mass cytometry and machine learning predict relapse in childhood leukemia

Jolanda Sarno et al.

MOLECULAR & CELLULAR ONCOLOGY (2018)

Review Biochemistry & Molecular Biology

Clonal evolution in leukemia

Adolfo A. Ferrando et al.

NATURE MEDICINE (2017)

Article Biochemical Research Methods

Salmon provides fast and bias-aware quantification of transcript expression

Rob Patro et al.

NATURE METHODS (2017)

Review Hematology

Targeting the B-cell receptor signaling pathway in B lymphoid malignancies

Maike Buchner et al.

CURRENT OPINION IN HEMATOLOGY (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Biochemical Research Methods

Normalization of mass cytometry data with bead standards

Rachel Finck et al.

CYTOMETRY PART A (2013)

Review Immunology

New insights into pre-BCR and BCR signalling with relevance to B cell malignancies

Robert C. Rickert

NATURE REVIEWS IMMUNOLOGY (2013)

Review Multidisciplinary Sciences

Clonal evolution in cancer

Mel Greaves et al.

NATURE (2012)

Article Multidisciplinary Sciences

CREBBP mutations in relapsed acute lymphoblastic leukaemia

Charles G. Mullighan et al.

NATURE (2011)

Review Oncology

Glucocorticoid use in acute lymphoblastic leukaemia

Hiroto Inaba et al.

LANCET ONCOLOGY (2010)

Review Oncology

A History of Cancer Chemotherapy

Vincent T. DeVita et al.

CANCER RESEARCH (2008)

Article Multidisciplinary Sciences

Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia

Charles G. Mullighan et al.

SCIENCE (2008)

Review Biochemistry & Molecular Biology

Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance

S Schmidt et al.

CELL DEATH AND DIFFERENTIATION (2004)